Zhendong Chen - Researcher Profile | RDL Research Database

Publications

2 shown

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng , Yoon‐Koo Kang , Zhendong Chen +18 more

Most cases of hepatocellular carcinoma occur in the Asia-Pacific region, where chronic hepatitis B infection is an important aetiological factor. Assessing the efficacy and safe...

2008 The Lancet Oncology 5750 citations

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares , Mikhail Dvorkin , Yuanbin Chen +97 more

2019 The Lancet 2014 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,764
Institution: Anhui Medical University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2035-635X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.